Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

BACKGROUND: The aim of this study was to determine the clinical benefit of transhepatic arterial chemoembolization (TACE) with or without recombinant human adenovirus type 5 (H101) administration for the treatment of patients with hepatocellular carcinoma (HCC). METHODS: Tumor response, progression-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiao-jun, Li, Qi-jiong, Lao, Xiang-ming, Yang, Han, Li, Sheng-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608280/
https://www.ncbi.nlm.nih.gov/pubmed/26470869
http://dx.doi.org/10.1186/s12885-015-1715-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608280/
https://www.ncbi.nlm.nih.gov/pubmed/26470869
http://dx.doi.org/10.1186/s12885-015-1715-x

Ejemplares similares